Back to
HHLR ADVISORS, LTD.
MAZE
6 quarters
Position history for
HHLR ADVISORS, LTD.'s holdings in MAZE THERAPEUTICS INC
Yes. HHLR Advisors holds 366,028 shares of MAZE (Maze Therapeutics), worth $10.9M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. HHLR Advisors has held MAZE in every 13F on record since Q1 2025, 6 quarterly filings. MAZE is 1.3% of HHLR Advisors' reported 13F portfolio.
Current Value
$10.9M
Current Shares
366,028
Total Value Change
+$5.9M
Total Shares Change
-91,507
Quarter-by-Quarter History